Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001)

NCT04569786 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
232
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated based on an interim assessment of immunogenicity.

Conditions

Interventions

Sponsor

Merck Sharp & Dohme LLC